Dr. Daniel Weitz, MD

Dr. Weitz practices at Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health.

Dr. Weitz's NPI, 1568585289, was assigned on April 9, 2007. Dr. Weitz graduated from New York University School of Medicine in 2004. Dr. Weitz holds Florida license ME112180.

Dr. Weitz's primary practice is Holy Cross Health, at 4725 N Federal Hwy, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 771-8000.

Dr. Weitz's primary practice is Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health. Dr. Weitz is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is Holy Cross Medical Group. Dmand AI also links Dr. Weitz to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weitz practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Weitz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Weitz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Weitz's licenses on file in 3 states: Florida, New York and Connecticut.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Weitz treats.

CMS data shows 6,826 Medicare services from Dr. Weitz across 39 procedure codes in 2024, for 1,691 Medicare patients. Medicare paid $369,999 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,691 Medicare patients who saw Dr. Weitz in 2024. The largest group is 75 to 84, with 717 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weitz's median patient age at 76, with 39% women.

In 2024, Dr. Weitz wrote 439 Medicare Part D claims for 169 patients. 65% of them were for generic drugs. CMS names the drug for 349 of them, across 8 drugs with 11 or more claims each, at $99,828 in total drug cost. In 2023, CMS named 332 claims across 8 drugs.

Dr. Weitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weitz as offering telehealth. CMS counts 66 procedures of pacemaker insertion or repair by Dr. Weitz, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Weitz in 2017. Dr. Weitz's most frequent co-authors are Rishi Gujral Anand, MD, John Junyoung Lee, MD and Arthur Z. Schwartzbard, MD.

CMS Open Payments shows 1,031 general payments to Dr. Weitz from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Biosense Webster, Inc. paid the most, $11,037.

Dr. Weitz graduated from New York University School of Medicine in 2004.

Dr. Weitz is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.